The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: a Retrospective Study in a Single Center

Purpose: Nowadays, myelofibrosis can be cured only by allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the transplantation experience is very limited worldwide. We retrospectively investigated the treatment outcome of myelofibrosis patients post allo-HSCT at National Taiwan Univer...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Mei-Fang Hou, Hsin-An Hou, Chien-Ting Lin, Chi-Cheng Li, Ming Yao, Jie-Yang Jhuang, Chung-Wu Lin, Bor-Sheng Ko, Shang-Yi Huang, Wen-Chien Chou, Yao-Chang Chen, Hwei-Fang Tien, Jih-Luh Tang
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wolters Kluwer Medknow Publications 2015-03-01
Reeks:	Journal of Cancer Research and Practice
Onderwerpen:	myelofibrosis allogeneic hematopoietic stem cell transplantation infection prognosis graft-versus-host disease
Online toegang:	http://www.sciencedirect.com/science/article/pii/S231130061630057X
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!